Liver Fibrosis Device Webinar Presentation
Filed with ASX · · 31 pages · English
Summary by 6ix AI
Resonance Health Ltd has released preliminary results from its MRI Liver Fibrosis Device clinical trial, which will be discussed in an upcoming webinar. These preliminary findings are subject to further analysis and independent verification, emphasizing the investigational nature of the device.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Resonance Health
- Investor Presentation Liver Fibrosis Device & Capital Raise
- Proposed issue of securities - RHT
- $6.0 Million Placement Oversubscribed
- Liver Fibrosis Device - EPoC Study Results
- Trading Halt
Later from Resonance Health
- TrialsWest East-Coast Expansion - Executive Appointment
- Application for quotation of securities - RHT
- Cleansing Notice
- Alteration to Notice of Meeting
- MRI Muscle Endpoint - Product Update
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health